Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.
about
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.Berberine inhibits proliferation and down-regulates epidermal growth factor receptor through activation of Cbl in colon tumor cells.Genome-wide gene expression profiling of stress response in a spinal cord clip compression injury modelExpression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.Continuous hypoxic culturing of human embryonic stem cells enhances SSEA-3 and MYC levels.Tudor staphylococcal nuclease (Tudor-SN), a novel regulator facilitating G1/S phase transition, acting as a co-activator of E2F-1 in cell cycle regulation.PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response.The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer.Function and expression of prolyl hydroxylase 3 in cancers.Prolyl-hydroxylase 3: Evolving Roles for an Ancient Signaling ProteinProlyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.Molecular oxygen sensing: implications for visceral surgery.HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma.Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27.Patent Highlights October-November 2016.
P2860
Q33566604-1205855C-F783-4772-B587-35233A3CFA77Q34606977-44C7BE40-EF30-441F-B3C2-3DFA916E8C54Q34975709-EE1EEAC3-FB79-4BFE-9615-9061D409CF59Q35032951-8D95D24E-94F0-4E7C-A6B6-E174EDB0B057Q35043607-3E4B7D92-BFE4-4765-84A5-1F556AC733AAQ35172690-8BD0845E-47B9-4F91-A373-2E5E6355EDADQ36129082-A806E3BA-CA7A-402A-AB4B-C2DDEB6BF691Q36903218-64C0DF64-380C-4AE6-88D0-A435A426466AQ37180139-F3D98BFA-D67A-43C5-92B1-C042B1245CAFQ37657590-C8FC2691-2E71-4CD8-9506-822086D53B4AQ37706535-AA491B24-6EB7-4F4B-93CF-40B79E6EB136Q37991141-A05DFC45-A53A-432E-A6B3-AEE831584B3AQ38431622-22FA3C90-94C4-4CF0-B8FC-CBF0C7BD3FF0Q40681056-4405BB1C-A6C3-449D-AD6A-71BD289B818CQ54380711-F02D46ED-9E03-4C4E-B989-776BF71F89FD
P2860
Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prolyl hydroxylase PHD3 enhanc ...... transition of carcinoma cells.
@ast
Prolyl hydroxylase PHD3 enhanc ...... transition of carcinoma cells.
@en
Prolyl hydroxylase PHD3 enhanc ...... transition of carcinoma cells.
@nl
type
label
Prolyl hydroxylase PHD3 enhanc ...... transition of carcinoma cells.
@ast
Prolyl hydroxylase PHD3 enhanc ...... transition of carcinoma cells.
@en
Prolyl hydroxylase PHD3 enhanc ...... transition of carcinoma cells.
@nl
prefLabel
Prolyl hydroxylase PHD3 enhanc ...... transition of carcinoma cells.
@ast
Prolyl hydroxylase PHD3 enhanc ...... transition of carcinoma cells.
@en
Prolyl hydroxylase PHD3 enhanc ...... transition of carcinoma cells.
@nl
P2093
P2860
P1433
P1476
Prolyl hydroxylase PHD3 enhanc ...... transition of carcinoma cells
@en
P2093
Krista Rantanen
Reidar Grenman
Terhi Jokilehto
P2860
P304
P356
10.1371/JOURNAL.PONE.0027112
P407
P577
2011-11-08T00:00:00Z